Atlas Spine, Inc.

Worked as co-placement agent in placing $3.5 million in Series A Preferred Stock for Atlas Spine, Inc. with a single institutional investor. Proceeds from the sale were allocated toward inventory, product development, workforce expansion, and general working capital.